Linking the Who, What, When, and Where of Inpatient Direct Oral Penicillin Challenge With the How of Durable Penicillin Allergy Delabeling.
作者信息
Olans Richard N, Olans Rita Drummond
机构信息
Tufts Medicine, Melrose-Wakefield Hospital, Melrose, Massachusetts, USA.
MGH Institute of Health Professions, Boston, Massachusetts, USA.
出版信息
Clin Infect Dis. 2024 Jan 25;78(1):227. doi: 10.1093/cid/ciad478.
PMID:37585654
Abstract
摘要
相似文献
1
Linking the Who, What, When, and Where of Inpatient Direct Oral Penicillin Challenge With the How of Durable Penicillin Allergy Delabeling.将住院患者直接口服青霉素激发试验的何人、何事、何时及何地与持久青霉素过敏标签去除的方式联系起来。
Clin Infect Dis. 2024 Jan 25;78(1):227. doi: 10.1093/cid/ciad478.
2
Inpatient allergy delabeling of pediatric patients with low-risk penicillin allergy status through direct oral amoxicillin challenge.通过直接口服阿莫西林挑战，对低风险青霉素过敏状态的儿科住院患者进行过敏标签剔除。
Allergy Asthma Proc. 2024 Jan 1;45(1):61-69. doi: 10.2500/aap.2024.45.230069.
3
Successful pediatric inpatient penicillin allergy delabeling through direct oral challenges.通过直接口服激发试验成功去除儿科住院患者青霉素过敏标签
J Allergy Clin Immunol Pract. 2024 Aug;12(8):2193-2195. doi: 10.1016/j.jaip.2024.04.042. Epub 2024 Apr 29.
4
Penicillin allergy delabeling: Opportunities for implementation and dissemination.青霉素过敏标签去除：实施和推广的机会。
Ann Allergy Asthma Immunol. 2023 May;130(5):554-564. doi: 10.1016/j.anai.2022.12.023. Epub 2022 Dec 20.
5
Direct oral penicillin challenge for penicillin allergy delabeling as a health services intervention: A multicenter cohort study.将直接口服青霉素激发试验用于青霉素过敏标签去除作为一种卫生服务干预措施：一项多中心队列研究。
Allergy. 2022 Mar;77(3):1038-1042. doi: 10.1111/all.15169. Epub 2021 Nov 10.
6
The Who, What, When, and Where of Inpatient Direct Oral Penicillin Challenge-Implications for Health Services Implementation.住院患者直接口服青霉素挑战的“何人、何事、何时、何地”-对卫生服务实施的影响。
Clin Infect Dis. 2023 Jul 5;77(1):19-22. doi: 10.1093/cid/ciad156.
7
Low-risk penicillin allergy delabeling through a direct oral challenge in immunocompromised and/or multiple drug allergy labeled patients in a critical care setting.在重症监护环境中，通过对免疫功能低下和/或标记有多种药物过敏的患者进行直接口服激发试验，对低风险青霉素过敏进行去标签化处理。
J Allergy Clin Immunol Pract. 2022 Jun;10(6):1660-1663.e2. doi: 10.1016/j.jaip.2022.01.041. Epub 2022 Feb 5.
8
Low-risk penicillin allergy delabeling: a scoping review of direct oral challenge practice, implementation, and multi-disciplinary approaches.低风险青霉素过敏脱敏：直接口服激发试验实践、实施及多学科方法的范围综述
Expert Rev Anti Infect Ther. 2024 Jan-Jun;22(1-3):59-69. doi: 10.1080/14787210.2023.2296068. Epub 2024 Feb 12.
9
Delabeling of Penicillin Allergy: Room for Improvement.青霉素过敏标签修正：仍有改进空间。
Int Arch Allergy Immunol. 2023;184(9):870-874. doi: 10.1159/000530770. Epub 2023 Jun 15.
10
Delabeling penicillin allergy in a pediatric primary care clinic.在儿科初级保健诊所消除青霉素过敏标签
Ann Allergy Asthma Immunol. 2023 May;130(5):667-669. doi: 10.1016/j.anai.2023.01.034. Epub 2023 Feb 2.
Zotero 插件